{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:50:38Z","timestamp":1793163038249,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF125"],"award-info":[{"award-number":["DNRF125"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsbergfondet","doi-asserted-by":"publisher","award":["CF18-0314"],"award-info":[{"award-number":["CF18-0314"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003741","name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-104544GB-I00"],"award-info":[{"award-number":["PID2019-104544GB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-105017RB-100"],"award-info":[{"award-number":["PID2019-105017RB-100"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jbc.2021.101039","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:11:49Z","timestamp":1627758709000},"page":"101039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation"],"prefix":"10.1016","volume":"297","author":[{"given":"Sebasti\u00e1n A.","family":"Esperante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-8896","authenticated-orcid":false,"given":"Nathalia","family":"Varej\u0101o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Sant'Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Rom\u00e1n","family":"Luque-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4800","authenticated-orcid":false,"given":"Carlos","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-6351","authenticated-orcid":false,"given":"Salvador","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.101039_bib1","series-title":"Encyclopedia of the Neurological Sciences","author":"Aminoff Michael","year":"2014"},{"key":"10.1016\/j.jbc.2021.101039_bib2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101039_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2021.101039_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/joim.12506","article-title":"Current and future treatment of amyloid diseases","volume":"280","author":"Ankarcrona","year":"2016","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jbc.2021.101039_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1210\/jcem-37-3-415","article-title":"Transport of thyroid hormones in serum and cerebrospinal fluid","volume":"37","author":"Hagen","year":"1973","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2021.101039_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-5793(91)80387-I","article-title":"The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis","volume":"281","author":"Christmanson","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2021.101039_bib7","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00018-009-0109-0","article-title":"Transthyretin: The servant of many masters","volume":"66","author":"Buxbaum","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jbc.2021.101039_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ane.13035","article-title":"Hereditary transthyretin-related amyloidosis","volume":"139","author":"Finsterer","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jbc.2021.101039_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019052-199610000-00007","article-title":"Familial amyloid polyneuropathy: New developments in genetics and treatment","volume":"9","author":"Coelho","year":"1996","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jbc.2021.101039_bib10","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101039_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF02190707","article-title":"Transthyretin Leu 68 in a form of cardiac amyloidosis","volume":"86","author":"Almeida","year":"1991","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jbc.2021.101039_bib12","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/bi201365r","volume":"50","author":"Azevedo","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib13","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/bi027319b","article-title":"D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis?","volume":"42","author":"Hammarstr\u00f6m","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101039_bib15","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/0960-8966(96)88826-2","article-title":"Compound heterozygotes of transthyretin Met30 and transthyretin Met119 are protected from the devastating effects of familial amyloid polyneuropathy","volume":"6","author":"Coelho","year":"1996","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jbc.2021.101039_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: From delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2021.101039_bib17","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101039_bib18","first-page":"2802","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jbc.2021.101039_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.101039_bib20","article-title":"Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis","author":"Pinheiro","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2021.101039_bib21","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib22","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity","volume":"99 Suppl 4","author":"Hammarstr\u00f6m","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101039_bib23","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1074\/jbc.M114.563981","article-title":"The importance of a gatekeeper residue on the aggregation of transthyretin: Implications for transthyretin-related amyloidoses","volume":"289","author":"Sant'Anna","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/13816810.2011.599356","article-title":"Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg","volume":"33","author":"Long","year":"2012","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.jbc.2021.101039_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/13506129.2012.724035","article-title":"Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly","volume":"19","author":"Levy","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2021.101039_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<135::AID-AJMG5>3.0.CO;2-R","article-title":"Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis","volume":"77","author":"Patrosso","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.jbc.2021.101039_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/brain\/118.4.849","article-title":"Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy","volume":"118","author":"Reilly","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2021.101039_bib28","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1021\/bi991021c","article-title":"The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions","volume":"38","author":"Lashuel","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib29","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1021\/bi010673+","article-title":"Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: Insight into the chaotrope unfolding dichotomy","volume":"40","author":"Hammarstr\u00f6m","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1074\/jbc.M807100200","article-title":"Trapping the monomer of a non-amyloidogenic variant of transthyretin: Exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases","volume":"284","author":"Palhano","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1006\/bbrc.2000.2554","article-title":"Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M","volume":"270","author":"Almeida","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2021.101039_bib32","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-ray crystal structures of transthyretin: What do they tell us about this protein and the design of drugs for TTR amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib33","doi-asserted-by":"crossref","first-page":"25832","DOI":"10.1074\/jbc.M109.017657","article-title":"Amyloidogenic potential of transthyretin variants: Insights from structural and computational analyses","volume":"284","author":"Cendron","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib34","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation in\u00a0vitro","volume":"31","author":"Colon","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib35","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: The relationship between stability and amyloidosis","volume":"47","author":"Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib36","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1021\/bi011194d","article-title":"An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured","volume":"40","author":"Jiang","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib37","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.1021\/bi981876+","article-title":"Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: Implications for wild-type, V30M, and L55P amyloid fibril formation","volume":"37","author":"Lashuel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib38","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1021\/bi963195p","article-title":"Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: Equilibria with high kinetic barriers","volume":"36","author":"Lai","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13506120600722449","article-title":"R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2021.101039_bib40","doi-asserted-by":"crossref","first-page":"44709","DOI":"10.1038\/srep44709","article-title":"Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation","volume":"7","author":"Sant'Anna","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2021.101039_bib41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jmb.2005.01.050","article-title":"Kinetic stabilization of the native state by protein engineering: Implications for inhibition of transthyretin amyloidogenesis","volume":"347","author":"Foss","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2021.101039_bib42","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1126\/science.1062245","article-title":"Trans-suppression of misfolding in an amyloid disease","volume":"293","author":"Hammarstr\u00f6m","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.101039_bib43","doi-asserted-by":"crossref","first-page":"107290","DOI":"10.1016\/j.compbiolchem.2020.107290","article-title":"TTRMDB: A database for structural and functional analysis on the impact of SNPs over transthyretin (TTR) using bioinformatic tools","volume":"87","author":"Srinivasan","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib44","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.biochem.0c00079","article-title":"Disruption of the CD loop by enzymatic cleavage promotes the formation of toxic transthyretin oligomers through a common transthyretin misfolding pathway","volume":"59","author":"Dasari","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.101039_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-016-0040-x","article-title":"Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis","volume":"5","author":"Coelho","year":"2016","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jbc.2021.101039_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2021.101039_bib47","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1038\/ncomms10787","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant'Anna","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2021.101039_bib48","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1021\/acs.jmedchem.8b00817","article-title":"Enthalpy-driven stabilization of transthyretin by AG10 mimics a naturally occurring genetic variant that protects from transthyretin amyloidosis","volume":"61","author":"Miller","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2021.101039_bib49","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1073\/pnas.1300761110","article-title":"AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin","volume":"110","author":"Penchala","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101039_bib50","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","article-title":"Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling","volume":"78","author":"Schuck","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2021.101039_bib51","series-title":"Principles of Physical Biochemistry","author":"Van Holde","year":"2005"},{"key":"10.1016\/j.jbc.2021.101039_bib52","series-title":"Analytical Ultracentrifugation in Biochemistry and Polymer Science","author":"Harding","year":"1992"},{"key":"10.1016\/j.jbc.2021.101039_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1107\/S160057751400825X","article-title":"Developments in optics and performance at BL13-XALOC, the macromolecular crystallography beamline at the ALBA synchrotron","volume":"21","author":"Juanhuix","year":"2014","journal-title":"J.\u00a0Synchrotron Radiat."},{"key":"10.1016\/j.jbc.2021.101039_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2021.101039_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2021.101039_bib56","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.jbc.2021.101039_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: A comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2021.101039_bib58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2021.101039_bib59","doi-asserted-by":"crossref","first-page":"L47","DOI":"10.1016\/j.bpj.2011.03.051","article-title":"How robust are protein folding simulations with respect to force field parameterization?","volume":"100","author":"Piana","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2021.101039_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fmolb.2016.00078","article-title":"The mutational landscape of the oncogenic MZF1 SCAN domain in cancer","volume":"3","author":"Nygaard","year":"2016","journal-title":"Front. Mol. Biosci."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821008413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821008413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:34:55Z","timestamp":1762187695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821008413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0021925821008413"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101039","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101039"}}